CAS Number: 66357-35-5
Drug which is commonly used in pediatric therapy even for newborn treatment. Excreted in high amount into breast milk although infant intake is reportedly lower than usual therapeutic dose. No side effects on breastfed babies have been reported. Increase of Prolactin levels has been shown, yet it does not induce galactorrhea.
CAS Number: 66357-35-5
Although interpatient variability exists, the dose of ranitidine in breastmilk is less than the dose used in newborn infants. Maternal ranitidine would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.
Zantac | Ranitidine Tablet is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Zantac | Ranitidine Tablet you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
Definitely, Zantac | Ranitidine Tablet is safe in lactation for baby. No wonder your doctor has recommended it.
No extra baby monitoring required while mother is using Zantac | Ranitidine Tablet
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week